Search
for
Sort by
Research 30 of 1000+
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Tregs: Where We Are and What Comes Next?
- Biological therapy in the treatment of melanoma
- Role of the Wnt signaling pathway in keratoacanthoma
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Cutaneous manifestations associated with immune checkpoint inhibitors
- The JAK/STAT signaling pathway: from bench to clinic
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Lysophospholipid Mediators in Health and Disease
- Fibroblasts – the cellular choreographers of wound healing
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Protective Effect of Iris germanica L. Rhizome-Derived Exosome against Oxidative-Stress-Induced Cellular Senescence in Human Epidermal Keratinocytes
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Management of Toxicities of Targeted Therapies
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- The Dual Nature of Cellular Senescence: From Aging Signature to Regenerative Catalyst
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
- Vitiligo